BioSenic announces the approval and publication of the Prospectus for listing and admission to trading of the shares and subscription rights issued in the context of the capital increase by way of in kind contributions of Medsenic
REGULATED INFORMATION NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE TO OR WITHIN SWITZERLAND, THE UNITED STATES…
Arvig Deploys Wi-Fi 7 Speeds Network-Wide
Your Next Customer Isn’t Googling You. They’re Asking AI